STOCK TITAN

Vanguard amends Schedule 13G for Joint Corp/The (JYNT) after internal realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 3 to a Schedule 13G for Joint Corp/The reporting that, after an internal realignment, its filing shows 0 shares beneficially owned and 0% of the class. The amendment cites the January 12, 2026 realignment and SEC Release No. 34-39538 to explain that certain Vanguard subsidiaries will report ownership separately.

The filing lists the issuer as Joint Corp/The (principal executive offices at 16767 N Perimeter Dr, Suite 110, Scottsdale, AZ) and is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.

Positive

  • None.

Negative

  • None.





47973J102

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group report in the JYNT Schedule 13G/A amendment?

The amendment reports 0 shares beneficially owned and 0% of Joint Corp/The common stock. It explains an internal realignment on January 12, 2026 that led to separate reporting by certain Vanguard subsidiaries.

Why did Vanguard file Amendment No. 3 to the Schedule 13G for JYNT?

Vanguard amended to disclose an internal realignment effective January 12, 2026. In reliance on SEC Release No. 34-39538, certain subsidiaries now report beneficial ownership separately from The Vanguard Group, Inc.

Does the filing show any Vanguard voting or dispositive power over JYNT shares?

No. The filing states 0 sole and shared voting powers and 0 sole and shared dispositive powers for the reported shares, reflecting no voting or disposition authority in this filing.

Who signed the Schedule 13G/A amendment for JYNT and when was it signed?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/27/2026, attesting to the reported ownership and disclosures in the filing.

What issuer details are provided in the JYNT Schedule 13G/A amendment?

The filing identifies the issuer as Joint Corp/The with principal executive offices at 16767 N Perimeter Dr, Suite 110, Scottsdale, AZ, 85260, and lists the class as Common Stock.
Joint Corp

NASDAQ:JYNT

View JYNT Stock Overview

JYNT Rankings

JYNT Latest News

JYNT Latest SEC Filings

JYNT Stock Data

119.69M
11.86M
Medical Care Facilities
Patent Owners & Lessors
Link
United States
SCOTTSDALE